CINECA IRIS Institutional Research Information System

LUPETTI, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.760
EU - Europa 4.127
AS - Asia 4.124
SA - Sud America 659
AF - Africa 131
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.531
IT - Italia 1.670
SG - Singapore 1.295
CN - Cina 1.234
HK - Hong Kong 733
BR - Brasile 569
DE - Germania 541
SE - Svezia 489
BG - Bulgaria 275
GB - Regno Unito 220
VN - Vietnam 199
FI - Finlandia 176
CA - Canada 170
KR - Corea 164
TR - Turchia 160
RU - Federazione Russa 159
UA - Ucraina 142
FR - Francia 125
IN - India 99
AT - Austria 77
NL - Olanda 73
JP - Giappone 54
CH - Svizzera 50
CI - Costa d'Avorio 43
BE - Belgio 33
PL - Polonia 31
BD - Bangladesh 28
AR - Argentina 27
IQ - Iraq 26
MX - Messico 24
EC - Ecuador 19
ES - Italia 19
ZA - Sudafrica 19
MA - Marocco 18
MY - Malesia 15
SA - Arabia Saudita 15
VE - Venezuela 12
CO - Colombia 11
CZ - Repubblica Ceca 11
EG - Egitto 11
ID - Indonesia 11
IE - Irlanda 10
PK - Pakistan 10
SN - Senegal 10
NG - Nigeria 9
UZ - Uzbekistan 9
AU - Australia 8
PH - Filippine 8
IL - Israele 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
JM - Giamaica 6
PA - Panama 6
CL - Cile 5
KE - Kenya 5
AZ - Azerbaigian 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
TH - Thailandia 4
BB - Barbados 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SV - El Salvador 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BJ - Benin 2
DK - Danimarca 2
DZ - Algeria 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
NA - Namibia 2
RS - Serbia 2
TN - Tunisia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KN - Saint Kitts e Nevis 1
Totale 17.800
Salva come PNG Salva come JPEG
Città #
Ashburn 976
Woodbridge 779
Houston 777
Hong Kong 721
Singapore 721
Fairfield 718
Ann Arbor 674
Santa Clara 548
Chandler 507
Dallas 409
Milan 293
Seattle 275
Sofia 274
Shanghai 270
Wilmington 259
Beijing 249
Serra 241
Cambridge 229
New York 194
Hefei 191
Jacksonville 170
Seoul 163
Pisa 160
Boardman 153
Los Angeles 142
Princeton 141
Munich 138
Ottawa 138
Frankfurt am Main 116
Lawrence 111
Medford 104
Bremen 98
Izmir 92
Nanjing 91
Des Moines 73
Rome 73
Florence 68
London 63
Dearborn 60
Helsinki 59
Vienna 58
Dong Ket 57
Redondo Beach 50
São Paulo 48
Bern 47
Istanbul 44
Abidjan 43
San Diego 43
Tokyo 40
Buffalo 39
Lucca 39
Marseille 37
Nanchang 34
Jüchen 30
Council Bluffs 26
Warsaw 26
Brussels 23
Ho Chi Minh City 23
Redwood City 23
Columbus 20
Kunming 20
Ogden 20
Pune 20
Boulder 19
Rio de Janeiro 19
The Dalles 19
Turku 19
Washington 19
Nuremberg 18
Shenyang 18
Phoenix 17
Changsha 16
Jiaxing 16
Hebei 15
Guangzhou 14
Hanoi 14
Hyderabad 14
San Francisco 14
Chicago 13
Curitiba 13
Lancaster 13
Hangzhou 12
Livorno 12
Belo Horizonte 11
Brasília 11
Lappeenranta 11
Montreal 11
San Jose 11
Ankara 10
Boydton 10
Dakar 10
Paris 10
Amsterdam 9
Fuzhou 9
Lagos 9
Naples 9
Norwalk 9
Quanzhou 9
Quarrata 9
Johannesburg 8
Totale 12.808
Salva come PNG Salva come JPEG
Nome #
Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates 343
Maternal anthropometric variables and clinical factors shape neonatal microbiome 313
Comparative evaluation of antimicrobial activity of different types of ionic liquids 240
Evaluation of a multiplex Real-Time PCR assay for the diagnosis of human intestinal protozoa in Azienda Ospedaliero Universitaria Pisana 237
Diagnosis of bloodstream infections by mass spectrometry : present and future 235
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 216
Direct inoculation of positive blood cultures using the Phoenix system for antimicrobial susceptibility testing of both Gram-positive and Gram-negative bacteria 212
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy 199
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 197
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 196
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 193
CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates 193
A comparison of skin storage methods for oculoplastic surgery 189
Antimicrobial Activity of a New Aloe vera Formulation for the Hygiene of the Periocular Area 185
Molecular basis of resistance to azole antifungals. 183
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. 183
Anti-biofilm Activity of the synthetic peptide hLF 1-11 against different Candida species in Lumen Catheters. 183
99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus 182
Effects of Pseudomonas aeruginosa on immune functions. 180
Antifungal effect of the antimicrobial peptide hLF(1-11) on invasive infections with Candida albicans. 179
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 178
CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis 178
Radiopharmaceuticals: new antimicrobial agents 177
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections 174
Recent advances in the microbiological diagnosis of bloodstream infections 173
Comparative evaluation of six chromogenic media for presumptive yeast identification 173
Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification 172
Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11 166
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains 165
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 163
Detection of fungal infections using radiolabeled antifungal agents 160
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system 160
Radiotracers for fungal infection imaging 157
A new culture-based method for rapid identification of microorganisms in polymicrobial blood cultures by MALDI-TOF 156
CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells 156
Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus 155
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 152
Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. 151
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area 151
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 150
Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression 150
Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring 148
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 148
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 148
Candidacidal activities of human lactoferrin peptides derived from the N terminus 148
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 148
99mTc-Antimicrobial peptides: promising candidates for infection imaging 146
Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species 145
Graves’ orbitopathy presenting after botulinum toxin injections 145
Identification of Bacillus species: Implication on the quality of probiotic formulations 145
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 143
Characterization of the chemotaxis fliY and cheA genes in Bacillus cereus 143
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections 142
Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. 142
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters 142
Molecular monitoring of Candida albicans infections in liver transplant recipients 142
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 141
Identification of Candida albicans karyotypes characterized by a high proteolytic activity 140
Molecular targeted treatments for fungal infections: the role of drug combinations 140
Radiochemical and biological characteristics of Technetium-99m labelled fluconazole 138
Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 138
A Rapid Procedure for Identification and Antifungal Susceptibility Testing of Yeasts From Positive Blood Cultures 138
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS 137
Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment 137
A comparison for skin storage methods for oculoplastic surgery 137
FlhF Is Required for Swarming Motility and Full Pathogenicity of Bacillus cereus 136
99mTc-labelled antimicrobial peptides for detection of bacterial and Candida albicans infections 135
Caratterizzazione genotipica di Candida albicans 134
Synergistic activity between colistin and the ionic liquids 1-methyl-3 dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1 dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria 134
Radiolabelled antimicrobial peptides for infection detection 134
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species 133
Graves’ orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation 132
Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. 131
MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives 131
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 130
Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide 130
Rapid identification and antibiotic susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 System 129
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains 126
Proteolytic activity and SAP gene expression in Candida albicans strains having different karyotypes 126
Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation 125
Erratum to: Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy (Frontiers in Medicine, (2018), 5, 10.3389/fmed.2018.00059) 123
Imaging of infections with Candida albicans with 99mTc-labelled antimicrobial peptides and the antifungal agent fluconazole. 121
New rapid methods cannot replace the current method to diagnose bloodstream infections. 121
In vitro resistance and evolution of resistance to tavaborole in Trichophyton rubrum 119
null 118
Role of cpals4790 and cpals0660 in candida parapsilosis virulence: evidence from a murine model of vaginal candidiasis 118
Comparison of molecular typing methods for Candida albicans strain delineation. 117
A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures 115
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 115
Letter to the Editor 113
Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center 112
Anti-Staphylococcal Biofilm Effects of a Liposome-Based Formulation Containing Citrus Polyphenols 111
Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry 110
Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology 110
Technetium-99m labelled antimicrobial peptides and anti-infectives for the detection of bacterial and Candida albicans infections. 109
MOLECULAR TYPING OF CANDIDA-ALBICANS IN ORAL CANDIDIASIS - KARYOTYPE EPIDEMIOLOGY WITH HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS IN COMPARISON WITH THAT WITH HEALTHY CARRIERS 109
Letter to the Editor 108
Diagnosi batteriologica 107
Diagnosi batteriologica. 106
Rapid identification of nontuberculous mycobacteria directly from positive primary MGIT coltures by MALDI-TOF MS 106
Totale 15.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021798 0 0 0 0 0 85 72 117 156 73 106 189
2021/20221.256 28 86 16 97 189 154 36 75 80 66 50 379
2022/20231.826 201 193 114 221 244 207 15 136 330 14 130 21
2023/20241.476 138 163 166 106 236 264 43 35 39 65 71 150
2024/20254.647 94 183 84 216 470 436 479 257 420 552 596 860
2025/20262.579 307 589 528 335 499 321 0 0 0 0 0 0
Totale 18.300